You are here

  • Home
  • Archive
  • Volume 20, Issue 4
  • Coronary artery bypass surgery continues to remain the treatment of choice for multivessel coronary artery disease even in the era of new-generation drug-eluting stents

Article info

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Coronary artery bypass surgery continues to remain the treatment of choice for multivessel coronary artery disease even in the era of new-generation drug-eluting stents

Authors

  1. Correspondence to : Dr Friedrich W Mohr, Department of Cardiac Surgery, Herzzentrum, Struempellstrasse 39, Leipzig 04289, Germany; mohrf{at}medizin.uni-leipzig.de
View Full Text

Citation

Mohr FW, Davierwala PM
Coronary artery bypass surgery continues to remain the treatment of choice for multivessel coronary artery disease even in the era of new-generation drug-eluting stents
BMJ Evidence-Based Medicine 2015;20:142.

Publication history

  • First published July 3, 2015.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions